Literature DB >> 8058612

Effects of acute and chronic inflammation on the pharmacokinetics of prednisolone in rats.

V Garg1, Y Y Hon, W J Jusko.   

Abstract

The effects of acute and chronic stages of carrageenan-induced air-pouch inflammation on the pharmacokinetics of prednisolone were studied in male Wistar rats. Chronic inflammation produced a significant increase in the area under the curve (AUC) of prednisolone compared to control animals (6594 +/- 2144 vs 3530 +/- 2164 micrograms.hr/L). The effect of acute inflammation was not significant (AUC = 4996 +/- 3813). Both acute and chronic inflammation also reduced the in vitro plasma protein binding of prednisolone, the reduction being much greater after chronic inflammation. The AUC of free prednisolone after chronic inflammation was 3141 micrograms.hr/L, compared to 1121 micrograms.hr/L in the control group and 1823 micrograms.hr/L after acute inflammation. The mean values of half-life and apparent volume of distribution at steady-state in each group were similar. These results indicate that prednisolone must be used with caution in the treatment of inflammatory diseases because of higher free concentrations of the steroid.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8058612     DOI: 10.1023/a:1018966516195

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  20 in total

1.  Adjuvant-induced arthritis and drug-metabolizing enzymes.

Authors:  M A Cawthorne; E D Palmer; J Green
Journal:  Biochem Pharmacol       Date:  1976-12-15       Impact factor: 5.858

2.  Alteration of Hepatic microsomal enzyme systems and the lethal action of non-steroidal anti-arthritic drugs in acute and chronic models of inflammation.

Authors:  R D Sofia
Journal:  Agents Actions       Date:  1977-07

3.  Corticosteroid analysis in biological fluids by high-performance liquid chromatography.

Authors:  J Q Rose; W J Jusko
Journal:  J Chromatogr       Date:  1979-03-01

4.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Abnormal drug metabolism in rats after an inflammatory insult.

Authors:  M W Whitehouse
Journal:  Agents Actions       Date:  1973-12

6.  Serum protein binding of prednisolone in four species.

Authors:  M L Rocci; N F Johnson; W J Jusko
Journal:  J Pharm Sci       Date:  1980-08       Impact factor: 3.534

7.  Hepatic drug metabolizing activity in rats with carrageenan-induced inflammation.

Authors:  M Ishikawa; K Sasaki; M Ozaki; K Watanabe; Y Takayanagi; K Sasaki
Journal:  J Pharmacobiodyn       Date:  1991-03

8.  Interleukin-6 inhibits corticosteroid-binding globulin synthesis by human hepatoblastoma-derived (Hep G2) cells.

Authors:  L Bartalena; G L Hammond; A Farsetti; I L Flink; J Robbins
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

9.  Prostaglandins: a possible mediator to inhibit hepatic drug metabolism in adjuvant arthritic rats.

Authors:  S Ishizuki; N Kanda; E Fujihira
Journal:  Biochem Med Metab Biol       Date:  1986-02

10.  A comparison of air pouch, sponge and pleurisy models of acute carrageenan inflammation in the rat.

Authors:  A D Sedgwick; P Lees
Journal:  Agents Actions       Date:  1986-06
View more
  4 in total

1.  Stability of dexamethasone sodium phosphate in rat plasma.

Authors:  Mahesh N Samtani; William J Jusko
Journal:  Int J Pharm       Date:  2005-09-14       Impact factor: 5.875

2.  Pharmacokinetic/pharmacodynamic modeling of methylprednisolone effects on iNOS mRNA expression and nitric oxide during LPS-induced inflammation in rats.

Authors:  Siddharth Sukumaran; Eve-Irene Lepist; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2012-03-16       Impact factor: 4.200

3.  Pharmacokinetics of dexamethasone in a rat model of rheumatoid arthritis.

Authors:  Justin C Earp; Nancy A Pyszczynski; Diana S Molano; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2008-09       Impact factor: 1.627

4.  Prophylactic efficacy of some chemoprotectants against abrin induced lethality.

Authors:  Nandita Saxena; Yangchen Doma Bhutia; Om Kumar; Pooja Phatak; Ramesh Kumar Kaul
Journal:  Interdiscip Toxicol       Date:  2019-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.